Effects of Auricular Acupressure on Relieving Pain in Postpartum Women With Episiotomy
NCT ID: NCT07277478
Last Updated: 2025-12-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2024-12-07
2025-09-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Auricular Acupuncture as Effective Pain Relief After Episiotomy
NCT03534869
Nonpharmacological Method for Relief of Episiotomy
NCT05649124
The Effects of Acupressure Applied to the Primiparous During Episiotomy
NCT06552104
The Effects of Acupressure on Pain After Cesarean Section
NCT04337801
The Effect of LI4 Acupressure on Perineal Pain and Postpartum Comfort During Episiotomy Repair
NCT06407505
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
auricular patch containing magnetic beads
After placental delivery, the intervention group received routine care plus a transparent patented auricular patch containing magnetic beads, while the control group received a transparent patented auricular patch without magnetic beads. The selected acupoints included internal genitalia (TF2), external genitalia (HX4), Shenmen (TF4), sympathetic (AH6a), and subcortex (AT4).
auricular patch
After placental delivery, the intervention group received routine care plus a transparent patented auricular patch containing magnetic beads, while the control group received a transparent patented auricular patch without magnetic beads. The selected acupoints included internal genitalia (TF2), external genitalia (HX4), Shenmen (TF4), sympathetic (AH6a), and subcortex (AT4)
auricular patch without magnetic beads
After placental delivery, the intervention group received routine care plus a transparent patented auricular patch containing magnetic beads, while the control group received a transparent patented auricular patch without magnetic beads. The selected acupoints included internal genitalia (TF2), external genitalia (HX4), Shenmen (TF4), sympathetic (AH6a), and subcortex (AT4).
auricular patch
After placental delivery, the intervention group received routine care plus a transparent patented auricular patch containing magnetic beads, while the control group received a transparent patented auricular patch without magnetic beads. The selected acupoints included internal genitalia (TF2), external genitalia (HX4), Shenmen (TF4), sympathetic (AH6a), and subcortex (AT4)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
auricular patch
After placental delivery, the intervention group received routine care plus a transparent patented auricular patch containing magnetic beads, while the control group received a transparent patented auricular patch without magnetic beads. The selected acupoints included internal genitalia (TF2), external genitalia (HX4), Shenmen (TF4), sympathetic (AH6a), and subcortex (AT4)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Women who underwent episiotomy.
3. Gestational age between 37 and 42 weeks.
4. Willing to participate in the study and provide signed informed consent.
5. Age 18 years or older.
Exclusion Criteria
2. Women with gynecological disorders, such as uterine fibroids, adenomyosis, or endometriosis.
3. Women or newborns with severe postpartum complications, such as postpartum hemorrhage, infection, perineal hematoma, major neonatal diseases, or admission to the neonatal intensive care unit.
4. Women with psychiatric disorders, such as anxiety or depression.
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
HSIAO AI WEN
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
HSIAO AI WEN
Nurse
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
AI WEN HSIAO
Role: STUDY_CHAIR
National Taipei University of Nursing and Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hsiao Ai Wen
Taipei, Sanchong, Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FJUH113431
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.